Mount Sinai Dermatology Experts Present Three Late-Breaking Research Papers at European Academy of Dermatology and Venereology Congress 2023
Announce discoveries in atopic dermatitis, eczema, and hidradenitis suppurativa
The Kimberly and Eric J. Waldman Department of Dermatology at Mount Sinai is proud to be presenting three of the 36 accepted late-breaking research papers at this year’s European Academy of Dermatology and Venereology (EADV) Congress in Berlin, Germany, Wednesday, October 11-Saturday, October 14, 2023. Earning these coveted spots underscores the department’s mission to advance the science of dermatology through research and clinical innovation.
The EADV Annual Congress is one of the most prestigious events in the field of dermatology and venereology. The late-breaker sessions at the EADV Annual Congress have become a key highlight for attendees, offering a platform for the most cutting-edge research that emerged in the months leading up to the event. These sessions showcase studies that are poised to make a significant impact on the diagnosis, treatment, and understanding of dermatological and venereological conditions.
The Department of Dermatology at Mount Sinai also has nine other activities at the EADV Annual Congress, totaling 12 contributions to this year’s meeting.
“A pool of many hundreds of late-breaking research papers are submitted globally,” notes Emma Guttman, MD, PhD, Waldman Professor and System Chair, The Kimberly and Eric J. Waldman Department of Dermatology. “There is always such a high caliber of late-breaking research papers presented at the EADV Annual Congress. We are extremely honored and humbled to contribute three of these papers this year, highlighting some of the latest discoveries and innovations in atopic dermatitis, chronic hand eczema and hidradenitis suppurativa.”
Mount Sinai’s late-breaking research contributions at this year’s EADV Annual Congress are:
D1T01.1: Late-breaking news
3599 Tape Strip Genomic Profiling Identifies Abrocitinib-Mediated Changes in Immune, Barrier, and Itch Biomarkers in the Skin of Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of the Phase 2a trial
Embargoed October 13, 11:30 am EDT
-Emma Guttman, MD, PhD, Waldman Professor and System Chair, The Kimberly and Eric J. Waldman Department of Dermatology; Director, Center of Excellence in Eczema; Director, Laboratory of Inflammatory Skin Diseases at the Icahn School of Medicine at Mount Sinai
D2T01.3: Late-breaking news
6542 Chronic hand eczema shares a common molecular signature regardless of atopic dermatitis status
Embargoed October 12, 8:30 am EDT
-Jonathan Bar, MD, Dermatologist and Postdoctoral Fellow, The Kimberly and Eric J. Waldman Department of Dermatology, Icahn Mount Sinai
D2T01.3: Late-breaking news
6607 Skin Tape stripping is a minimally invasive approach that accurately detects biomarkers of early and chronic disease in hidradenitis suppurativa
Embargoed October 12, 10:30 am EDT
-Kristina Navrazhina, MD, PhD, Dermatology Resident, The Kimberly and Eric J. Waldman Department of Dermatology, Icahn Mount Sinai (2024)
For a list of other activities contributed to this year’s EADV Annual Congress from the Department of Dermatology at Mount Sinai, or to learn more about these late-breaking research papers, please contact Laura Ruocco-Duran at Laura.Ruocco-Duran@mountsinai.org or at 646-877-6727.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, more than 400 outpatient practices, more than 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,400 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report's® “Best Hospitals” Honor Roll for 2023-2024.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across eight hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2024-2025.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term Results
Dec 09, 2022 View All Press Releases